Home
About
FAQ
History (10)
Methotrexate for pityriasis lichenoides et varioliformis acuta (Mucha-Habermann disease) and pityriasis lichenoides chronica: a retrospective case series of 33 patients with an emphasis on outcomes.
Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas.
The Arg-62 residues of the TREX1 exonuclease act across the dimer interface contributing to catalysis in the opposing protomers.
Impact of content-specific email reminders on provider participation in an online intervention: a dental PBRN study.
Treatment Update of Autoimmune Blistering Diseases.
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Treatment Update of Autoimmune Blistering Diseases.
Kridin K, Ahn C, Huang WC, Ansari A, Sami N. Treatment Update of Autoimmune Blistering Diseases. Dermatol Clin. 2019 Apr; 37(2):215-228.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Autoimmune Diseases
Dermatitis Herpetiformis
Epidermolysis Bullosa Acquisita
Female
Glucocorticoids
Humans
Immunoglobulins, Intravenous
Immunologic Factors
Immunosuppressive Agents
Immunotherapy, Adoptive
p38 Mitogen-Activated Protein Kinases
Pemphigoid Gestationis
Pemphigoid, Benign Mucous Membrane
Pemphigoid, Bullous
Pemphigus
Plasmapheresis
Pregnancy
Protein Kinase Inhibitors
Skin Diseases, Vesiculobullous
authors with profiles
Christine Ahn MD